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Abstract
A major system for net transepithelial secretion of a wide range of hydrophobic organic anions (OAs) exists in the proximal renal tubules
of almost all vertebrates. This process involves transport into the cells against an electrochemical gradient at the basolateral membrane and
movement from the cells into the lumen down an electrochemical gradient. Transport into the cells at the basolateral membrane, which is the
dominant, rate-limiting step, is a tertiary active transport process, the final step which involves countertransport of the OA into the cells
against its electrochemical gradient in exchange for a-ketoglutarate moving out of the cells down its electrochemical gradient. The outwardly
directed gradient for a-ketoglutarate is maintained by metabolism (f 40%) and by transport into the cells across both the basolateral and
luminal membranes by separate sodium-dicarboxylate cotransporters (f 60%). The inwardly directed sodium gradient driving a-
ketoglutarate uptake is maintained by the basolateral Na+–K+–ATPase, the primary energy-requiring transport step in the total tertiary
process. The basolateral OA/a-ketoglutarate exchange process now appears to be physiologically regulated by several factors in mammalian
tubules, including peptide hormones (e.g., bradykinin) and the autonomic nervous system acting via protein kinase C (PKC) pathways and
epidermal growth factor (EGF) working via the mitogen-activated protein kinase (MAPK) pathway.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
A major system for the net secretion of a wide range of
hydrophobic organic anions (or weak organic acids that
exist as anions at physiological pH; collectively OAs)
apparently exists in the renal tubules of all vertebrates
studied except a species of urodele amphibian (Necturus
maculosus) [1,2] and a species of hagfish (Myxine gluti-
nosa) [3,4]. The renal tubules of M. glutinosa apparently do
not transport OAs [3,4] and those of N. maculosus show net
reabsorption of some OAs (although net secretion is occa-
sionally observed) or no net transport of other OAs [1,2].
The general OA secretory system found in most verte-
brates involves transport from the blood (or peritubular) side
of the renal tubule across the epithelium into the tubule
lumen. Indeed, it was this system that E.K. Marshall used in
the late 1920s to demonstrate in the aglomerular goosefish
(Lophius piscatorius) that renal tubules could secrete sub-
stances (i.e., transport them from blood to tubule fluid) [5].
In these animals, OA could not be contributed to the urine
by filtration. Some of the substances secreted by this
system, e.g., organic dyes, could be measured easily by
the techniques available in the 1920s and 1930s. As techni-
ques became available to study the transport of inorganic
ions, such as Na+ and K+, interest in OA secretion declined
until quite recently. This is unfortunate because the OA
transport system, although capable of secreting a number of
endogenous compounds, is particularly effective in secret-
ing numerous exogenous compounds, including many phar-
macologically active substances, environmental toxins, and
plant and animal toxins. It also secretes toxic metabolic
breakdown products of exogenous and endogenous com-
pounds. Indeed, its primary function appears to be the
effective removal of such substances from the body.
Although there are a number of other systems for trans-
porting specific types of OAs in either the secretory or
reabsorptive directions, I will not discuss these in any detail
here. I shall concentrate on only a few aspects of the general
system for the net secretion of OAs, with para-amino-
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hippurate (PAH) and fluorescein (FL) as the prototypical
transported anions.
2. Transepithelial transport
The technique of perfusing segments of renal tubules
teased from fresh tissue without the aid of enzymatic agents
has been used by many laboratories, including ours, to
demonstrate initially or to confirm many aspects of the net
secretory process for OAs. As indicated in Table 1, the
proximal tubule has been shown by this technique to be the
site of net secretion in representative species from all five
vertebrate classes. However, the portion of the proximal
tubule that is most important for net secretion varies among
species (Table 1).
Saturation of the net transepithelial transport system has
been demonstrated by both the clearance technique and the
isolated perfused tubule technique in species across the
vertebrate classes, and Kt and Jmax values for the transport
of prototypical OAs have been determined for a number of
mammalian and nonmammalian species [6–10]. The kinetic
values for mammalian (rabbit) tubules are about the same
whether one looks at transepithelial transport or at transport
into the cells at the basolateral side only, thereby indicating
that the basolateral entry step is the rate-limiting step [9,11].
During the net transepithelial secretory process in iso-
lated perfused mammalian and nonmammalian renal prox-
imal tubules, the steady-state concentration of OA in the
tubule lumen is greater than that in the peritubular bathing
medium and the concentration in the cells is greater than
that in either the lumen or the peritubular bathing medium
[12,13]. Because the inside of the cells is negative compared
with the lumen and the peritubular fluid, because these
compounds are transported as anions at physiological pH,
and because they do not appear to be bound inside the cells,
these data are compatible with transport into the cells
against an electrochemical gradient at the basolateral mem-
Table 1
Tubule site of transport of organic anions
Species Tubule site References
Fishes (flounder) Proximal tubule (all portions) [6]
Amphibians (frog) Proximal tubule
(early and intermediate portions)
[8]
Reptiles (snake) Proximal tubule (distal portion) [7]
Birds (chicken) Proximal tubule (all portions) [31]
Mammals (rabbit) Proximal tubule (S2 portion) [73]
Fig. 1. Descriptive model of the steps in transepithelial transport of organic anions in proximal renal tubules, with PAH as a model substrate. This is based on
work on mammals, birds, reptiles, amphibians, and fishes. Values for luminal ( PL) and peritubular ( PL) membrane permeabilities are from those given in Table
2. Values for kinetic constants are from Refs. [6–10]. Broken arrows with open circles indicate movement down an electrochemical gradient. Solid arrows with
open circles indicate movement against an electrochemical gradient by some form of secondary active transport. Solid arrows and solid circle indicate primary
active transport. A indicates anion of unknown type; aKG2 represents a-ketoglutarate. Broken arrow with question mark indicates some form of possible
feedback from transport step across luminal membrane to transport step across basolateral membrane.
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brane and movement from the cells into the lumen down an
electrochemical gradient. This process appears to be essen-
tially the same for perfused flounder, frog, snake, chicken,
and rabbit tubules and, indeed, is the accepted process for
transepithelial secretion (Fig. 1).
The apparent permeabilities of the luminal and baso-
lateral membranes to PAH have been measured from the
fluxes across these membranes in isolated tubules from
frogs, snakes, and rabbits (Table 2) [7,8,12,13]. The appa-
rent permeability of the luminal membrane is always sub-
stantially greater than that of the basolateral membrane. This
is appropriate and in agreement with the general model if
PAH transported into the cells at the basolateral membrane
is to move into the lumen and not back into the bath. For
tubules from most species, the backflux of PAH from lumen
to peritubular bathing medium is small and, for the species
shown in Table 2, can be predicted almost perfectly from
these independently measured luminal and basolateral mem-
brane permeabilities, thus indicating that this small backflux
occurs across the cells [12–14].
3. Basolateral transport
Although it could easily be shown that transport into the
tubule cells across the basolateral membrane required
energy [15,16], it could never be shown that it was a
primary active transport process, i.e., that it was directly
linked to the hydrolysis of ATP [17,18]. Moreover, although
the process was shown to be Na+-dependent, it could not be
shown that it was directly linked to the Na+-gradient [19–
23]. However, evidence for (1) basolateral PAH/PAH
exchange [19,21,22]; (2) inhibition of basolateral PAH
uptake by the anion exchange inhibitor SITS [24]; (3)
inhibition or stimulation of basolateral PAH uptake by a
number of anionic metabolites, whose entry across the
basolateral membrane was directly coupled to the Na+-
gradient; and (4) production of a brief basolateral uptake
of PAH above equilibrium by a combination of an out-
wardly directed PAH or OH gradient and an inwardly
directed Na+-gradient [21,25] suggested to a number of
investigators that PAH entry across the basolateral mem-
brane might involve exchange for an anionic metabolite
[19,23,26,27]. In 1987 and 1988, Burckhardt and Pritchard
and their co-workers, using rat basolateral membrane
vesicles (BLMV), extended this concept to develop the
model shown in Fig. 1 [28–30]. In this model, transport
into the cells of PAH (or other OAs that share this system)
at the basolateral membrane is a tertiary active transport
process, the final step in which is the countertransport of
PAH against its electrochemical gradient in exchange for an
intracellular dicarboxylate [physiologically, a-ketoglutarate
(aKG)] moving down its electrochemical gradient. The
outwardly directed gradient for aKG is maintained in turn
by metabolism and by transport into the cells across the
basolateral membrane by the Na+-dicarboxylate co-trans-
port system (Fig. 1). The inwardly directed Na+-gradient
driving this process is maintained by the primary energy-
requiring transport step in the process, the transport of Na+
out of the cells by Na+–K+–ATPase at the basolateral
membrane.
As noted above, this model was initially developed in
studies using rat basolateral membrane vesicles. We have
demonstrated that it apparently does hold for OA transport
in intact single perfused snake, chicken, and rabbit tubules
[11,31–33]. When tubules are preloaded with aKG from the
bathing medium, both uptake of PAH into the cells and net
transepithelial secretion increase to a comparable extent as
illustrated for snake renal tubules in Fig. 2. This stimulatory
effect is eliminated if the preloading of the tubules with
aKG via the Na+-dicarboxylate cotransporter is prevented
by inhibiting this transporter with Li+ [31–33]. Analysis of
the kinetics of PAH uptake at the basolateral membrane of
isolated rabbit tubules clearly showed that the increase in
PAH uptake with aKG preloading results from an increase
in Jmax with little change in Kt [11]. We also demonstrated
the basolateral countertransport of PAH for aKG by meas-
uring the stimulatory effect of aKG in the bathing medium
on the rate of efflux of PAH across the basolateral mem-
brane of tubules already loaded with PAH (i.e., the reverse
effect) when the Na+-dicarboxylate cotransporter was
inhibited [32,33].
The metabolic state of the tubules, and thus their pro-
duction of intracellular aKG, appears to be important (see
below) especially for mammalian renal tubules. For exam-
ple, in the case of rabbit tubules, the control level of PAH
secretion is about five times as high when the tubules are
perfused and bathed in a bicarbonate/CO2-buffered medium
as when they are perfused and bathed with any other buffer
system (e.g., HEPES, Tris, phosphate) ([11]; S Shpun and
W.H. Dantzler, unpublished observations). Moreover, appa-
rently because of this high control rate of PAH secretion,
transport is stimulated only about two-fold by aKG pre-
loading in a bicarbonate/CO2-buffered medium [11],
whereas it is stimulated about four-fold by aKG preloading
in HEPES-buffered medium [33]. Although metabolic pro-
duction of aKG must also be important for PAH transport
by snake renal tubules, the stimulation of such transport by
preloading with aKG is not influenced by the buffer system
used (W.H. Dantzler, unpublished observations). This effect
has not been studied with renal tubules from any other
species.
We have evaluated the relative roles of metabolism and
uptake via the basolateral Na+-dicarboxylate cotransporter
Table 2
Apparent permeabilities of tubule cell membranes to PAH
Species Luminal membrane
(cm s 110 5)
Peritubular membrane
(cm s 110 5)
References
Frog 3.8 0.7 [8]
Snake 3.5 0.5 [7,12]
Rabbit 5.9 0.4 [13]
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in establishing the outwardly directed gradient for aKG in
nonperfused and perfused rabbit tubules under a close
approximation to physiological conditions (bicarbonate/
CO2 buffer, the presence of other metabolic substrates,
physiological concentration of aKG) [34,35]. In these
studies, we examined transport in real time by using
epifluorescence microscopy and observing the transport of
FL, which is also transported by this general OA transport
system, rather than PAH. Uptake of 1 AM FL by non-
perfused rabbit proximal tubules is linear for the first 25 s
and this initial rate of uptake is absolutely reproducible for
at least 3 h (Fig. 3) [35]. When we examined the effects of
preloading the tubules with aKG (trans configuration) on
this initial rate of uptake, we found that a concentration of
10 AM in the bathing medium (approximately the normal
plasma concentration) was as effective as 100 AM used
Fig. 2. Comparison of net transepithelial secretory transport of PAH ( JPAH)
(A) and cell concentrations of PAH (B) between control and aKG-loaded
snake proximal renal tubules from the same kidney studied in parallel.
Results are meansF S.E. *Group means that are significantly ( P< 0.05)
different from control values. From Ref. [32] with permission.
Fig. 3. (A) Fluorescence profile of an intact rabbit proximal S2 renal tubule
exposed first to a superfusion buffer containing 1 AM FL (FL influx) and
then to a buffer containing no FL (efflux). (B) Initial rates of FL uptake into
an intact rabbit renal proximal S2 tubule measured using a brief-exposure
protocol and a superfusion buffer containing 1 AM FL and 20 AM aKG in a
cis– trans configuration. The 4 uptake rates shown are representative of 15
initial rates of FL uptake measured over a 3-h period. From Ref. [35] with
permission.
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previously in the studies noted above (Fig. 4) [35]. Since the
cis– trans configuration for the presence of aKG (tubules
preloaded in the presence of 10 AM aKG to establish the
trans configuration and then maintained with 10 AM aKG
Fig. 4. (A) Stimulation of uptake of 1 AM FL into intact rabbit renal
proximal S2 tubules resulting from exposure to 10 or 100 AM aKG in the
trans-configuration. Each bar is meanF S.E. (n= 18) of the initial rate of
FL uptake compared with the average rate of uptake measured in aKG-free
buffer (controls). *Mean initial rate of FL uptake that is significantly
( P= < 0.05) different from paired controls. (B) Effect of cis, trans, and cis–
trans configurations of 10 AM aKG on the initial rate of FL uptake into
intact rabbit renal proximal S2 renal tubules. Tubules were exposed to each
of the transmembrane configurations of 10 AM aKG prior to measurement
of the initial rate of 1 AM FL uptake. Each bar is meanF S.E. of initial rate
of FL uptake in 8–11 tubules compared with the initial rate of uptake
measured in absence of aKG. *Mean initial rate of FL uptake that is
significantly ( P=< 0.05) different from paired controls. From Ref. [35]
with permission.
Fig. 5. (A) Effect of sodium removal on the initial rate of uptake of 1 AM
FL into single rabbit renal proximal S2 tubules. Sodium in the experimental
uptake medium was replaced with N-methyl-D-glucamine (NMDG).
Buffers did not contain aKG. Each bar is meanF S.E. of initial rate of
FL uptake in five tubules. *Mean initial rate of FL that is significantly
( P< 0.05) different from paired controls. (B) Effect of 2 mM LiCl and 1
mM methylsuccinate (MS) on the initial rate of uptake of 1 AM FL into
single rabbit renal proximal S2 tubules. Buffers did not contain aKG. Each
bar is meanF S.E. of two to three sequential measurements of FL uptake in
the presence of one or both of the test agents. Control bar is meanF S.E. of
nine measurements of initial rate of uptake measured before and after each
of the test conditions. *Initial rate of FL uptake that is significantly
( P< 0.05) different from controls. From Ref. [35] with permission.
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on the cis or outside of the membrane to establish the cis–
trans configuration) would represent the normal situation,
we compared this configuration with the cis and trans
configurations alone (Fig. 4) [35]. As shown in Fig. 4, there
is no significant difference between these configurations, the
average increase compared with control being f 75%.
However, this lack of significant difference is partially due
to the scatter in the experiments because all but one of the
experiments in the cis– trans configuration showed more
rapid uptake than experiments in the trans configuration
alone [35]. We were also interested in the significance of
recycling (by the Na+-dicarboxylate cotransporter) of aKG
that has moved out of the cells in exchange for an OA in
maintaining an outwardly directed aKG gradient sufficient
for continued OA uptake. To examine this question, we
determined the effect of inhibiting the Na+-dicarboxylate
cotransporter (with no added aKG in the bathing medium)
on the rate of FL uptake [35]. The results are shown in Fig.
5. Blocking the Na+-dicarboxylate cotransporter by remov-
ing Na+ from the bathing medium (replacement with N-
methyl-D-glucamine) has a profound effect on FL uptake
(Fig. 5). However, such a maneuver could have additional
effects that could interfere with FL uptake. Therefore, we
inhibited the Na+-dicarboxylate transporter specifically
exposing it to Li+, by saturating it with a high concentration
of methylsulfate (which is transported by this transporter but
does not exchange for FL), or by a combination of the two.
Both maneuvers have a significant inhibitory effect on FL
uptake (but less than Na+ replacement) and they are not
additive (Fig. 5). The consistent observation that selective
inhibition of the Na+-dicarboxylate cotransporter in the
absence of exogenous aKG reduces FL transport by
f 25% suggests that f 25% of the peritubular OA/aKG
exchange activity requires the parallel activity of the Na+-
dicarboxylate cotransporter.
Essentially the same response is observed if we measure
not just the rate of basolateral uptake of FL but the trans-
epithelial transport of FL in real time. We developed a
method to make these measurements [34]. This involves
epifluorescent microscopic measurement of the appearance
of FL in the collected perfusate from isolated perfused
tubules. Using this technique, we found that the addition
of Li+ to the bathing medium in the absence of exogenous
aKG reduces net transepithelial transport of FL by f 25%
(Fig. 6) [34]. This is the same degree of depression as seen
with FL uptake at the basolateral membrane (see above).
Thus, f 25% of basolateral OA/aKG exchange and the
resulting transepithelial transport requires the parallel activ-
ity of the basolateral Na+-dicarboxylate cotransporter.
From these studies, we have developed a quantitative
estimate of the relative importance of metabolism and
basolateral uptake via the Na+-dicarboxylate cotransporter
in establishing and maintaining the outwardly directed aKG
gradient for basolateral OA/aKG exchange, at least for
rabbit tubules (Fig. 1) [34,35]. Recycling of aKG across
the peritubular membrane supports f 25% of the ‘‘basal’’
activity of the OA/aKG exchanger, i.e., the activity that is
supported by cellular metabolism alone. However, the baso-
lateral membrane at steady-state is also exposed to aKG in
the cis– trans configuration. Under this configuration, aKG
increases the rate of FL transport by f 75% over the basal
rate, presumably by increasing the cytoplasmic concentra-
tion of aKG over that produced by metabolism alone. These
two observations suggest that the basolateral Na+-dicarbox-
Fig. 6. Representative tracing of effect 2 mM LiCl in bathing medium on net transepithelial secretion of FL in fmol min 1 mm 1 by a single rabbit renal
proximal S2 tubule in real time. FL concentration in bathing medium was 1 AM. Bars above tracing show periods when FL and LiCl were present in the bathing
medium. Data are taken from the studies reported in Ref. [34].
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ylate cotransporter is directly responsible for supporting
f 57% [(75 + 25%)/175%] of the total basolateral transport
of OA via the OA/aKG exchanger. This exchanger has been
cloned by two groups essentially simultaneously from the
rat kidney [36,37] and, slightly later, from flounder kidney
[38] and mouse kidney [39]. Orthologs have also now been
cloned from the human kidney [40,41] and, apparently, from
the rabbit kidney (A. Bahn and G. Burckhardt, personal
communication). It is generally referred to as OAT1 (for
Organic Anion Transporter 1).
Of course, aKG, which is circulating in the blood, is
filtered at the glomerulus and can be reabsorbed from the
lumen via a Na+-dicarboxylate cotransporter located on the
luminal membrane (Fig. 1). In rabbit renal tubules, this
luminal Na+-dicarboxylate cotransporter, which has been
cloned and sequenced [42], has a higher capacity than the
basolateral Na+-dicarboxylate cotransporter. We hypothe-
sized that uptake of aKG via this luminal transporter might
play a role in establishing the outwardly directed aKG
gradient at the basolateral membrane and, therefore, in
determining OA uptake across the basolateral membrane
via OA/aKG exchange. To test this possibility, we initially
examined the effect of adding aKG or glutarate (a non-
metabolized dicarboxylate that is also countertransported for
PAH at the basolateral membrane via OAT1) to the lumen of
perfused rabbit and snake tubules on net PAH secretion
([43]; W.H. Dantzler and K.K. Evans, unpublished obser-
vations). The addition of 100 AM aKG or glutarate to the
lumen (with none in the bathing medium) produces a
doubling of net transepithelial PAH secretion (Fig. 7). Since
this effect is the same with aKG and glutarate, it cannot be
the effect of aKG metabolism and, thereby, increased
energy production. When the luminal Na+-dicarboxylate
cotransporter is blocked by Li+, this stimulation is com-
pletely eliminated, but it can still be elicited when Li+ is
removed from the lumen (Fig. 7). Unfortunately, the initial
studies on rabbit tubules were performed under nonphysio-
logical conditions (with HEPES-buffered media instead of
bicarbonate/CO2-buffered media and with high concentra-
tions of aKG) [43]. At first, we could not repeat these under
more physiological conditions, and we suggested that
uptake of aKG from the lumen by the Na+-dicarboxylate
cotransporter only played a role in OA transport when
metabolism was depressed [43]. However, when we reex-
amined this question under a close approximation of phys-
iological conditions while measuring net transepithelial FL
transport in real time, we found that luminal uptake of aKG
is important [34]. The addition of f 20–50 AM aKG to the
lumen alone (with none in the bathing medium) produces a
significant increase in FL secretion of about 20% (Fig. 8)
[34]. Of even greater importance, the presence of 50 AM
aKG in the lumen in the presence of 10 AM aKG in the bath
Fig. 7. Effects of 100 AM aKG or glutarate in perfusate on net transepithelial secretion ( JPAH) of PAH in rabbit renal proximal S2 tubules perfused and bathed
in HEPES-buffered medium. Effect of 100 AM aKG in perfusate on JPAH also shown in the presence and absence of 4 mM LiCl in perfusate. Values for JPAH
are shown as percent of the mean control value (control being 100%) for each tubule for the first 20 min. Absolute mean rate of JPAH for all tubules for the first
20 min is given in fmol min 1 mm 1 (F S.E.). Solid circles are means of values for all tubules; vertical lines are F S.E.; n= 6. Arrows indicate when
substances were added to or removed from the perfusate. Data are taken from the studies reported in Ref. [43].
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produces a significant increase of about 15% over that
observed with aKG in the bathing medium alone (Fig. 9)
[34]. Putting all these observations together, we suggest
that, at least in rabbit tubules, the basolateral and luminal
Na+-dicarboxylate cotransporters together contribute about
60% to the aKG gradient and metabolism contributes about
40%. However, the luminal dicarboxylate transporter only
contributes about 14% of the total contributed by the two
dicarboxylate transporters (Fig. 1). Although the general
model of basolateral transport shown in Fig. 1 appears to
apply to fish, amphibian, reptilian, avian, and mammalian
tubules, the data on the relative roles of metabolism and
aKG transport in establishing the aKG gradient are only
complete for mammalian tubules.
Fig. 8. Representative tracing of effect of addition of 50, 100, or 200 AM aKG to perfusate on net transepithelial secretion of FL in fmol min 1 mm 1 by a
single rabbit renal proximal S2 tubule in real time. FL concentration in bathing medium was 1 AM. Bars above tracing show periods when FL and was present
in bathing medium and aKG was present at various concentrations in luminal perfusate. Data are taken from studies reported in Ref. [34].
Fig. 9. Representative tracing of effect of addition of aKG to bathing medium, perfusate, or both on net transepithelial secretion of FL in fmol min 1 mm 1 by
a single rabbit renal proximal S2 tubule in real time. FL concentration in bathing medium was 1 AM. Concentration of aKG was 10 AM in bathing medium and
50 AM in perfusate. Bars above tracing show when FL and aKG were present in bathing medium and when aKG was present in luminal perfusate. Data are
taken from studies reported in Ref. [34].
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4. Regulation of basolateral transport
Is this classical transport system for OAs at the baso-
lateral membrane regulated physiologically? Until quite
recently, this question had never been considered. However,
given the importance of this system in regulating the
concentrations of numerous endogenous organic com-
pounds and in eliminating toxic or potentially toxic xeno-
biotics, some form of regulation appears reasonable.
Sequence data on the cloned OAT1 reveal a number con-
sensus sites for phosphorylation of the transporter protein by
protein kinase C (PKC). This suggested that regulation
could involve activation of PKC. Indeed, before the trans-
porter was cloned, Hohage et al. [44] reported that PAH
uptake by isolated rabbit tubules was stimulated by activa-
tion of PKC with phorbol esters. In contrast, however,
Miller [45] and Takano et al. [46] reported inhibition of
OA uptake by PKC activation in killifish proximal tubules
and opossum kidney (OK) cells, respectively. We reex-
amined the question by evaluating the effects of PKC
activation on the initial rate of FL uptake in isolated non-
perfused rabbit tubules [47] and the transepithelial secretion
of FL in isolated perfused rabbit tubules [48]. We used four
different maneuvers, all known to lead to an activation of
PKC in the proximal tubule: addition to the bathing medium
of (1) 4-h-phorbol 12-myristate 13-acetate (PMA); (2) 1,2-
sn-dioctanylglycerol (DOG); (3) the a1-receptor agonist
phenylephrine (PE); or the peptide hormone bradykinin
(BK). Both PE and BK stimulate PKC via a ligand–
receptor –PKC coupling reaction. In the nonperfused
tubules, the addition of PMA or DOG to the bathing
medium induces a rapid and dramatic decrease in basolateral
FL uptake which is not reversible (Fig. 10) [47]. We
obtained a similar result on transepithelial secretion of FL
with perfused tubules [48]. Both BK and PE also signifi-
cantly decrease FL uptake in nonperfused tubules (Figs. 11
and 12) [47] and transepithelial FL secretion in perfused
tubules [48], but these effects are reversible when these
agents are removed from the bathing medium. To be certain
that the observed effects were indeed predominantly due to
PKC activation, we employed the PKC inhibitor bisindo-
lylmaleimide I (BIM) in a concentration at which no other
effects have been described. BIM reduces the inhibitory
effects of PMA, BK, and PE in nonperfused (Fig. 13) [47]
Fig. 10. Effect of PKC stimulation with PMA or DOG on initial rate of FL uptake in intact rabbit renal proximal S2 tubules. All values are normalized to the
last control measurement. Control contains only the vehicle (dimethylsulfoxide; final concentration: V 1:10,000) in which PMA or DOG was dissolved.
Symbols are meansF S.E. for each value plotted (n= 6). *P < 0.05 vs. last control measurement. From Ref. [47] with permission.
Fig. 11. Effect of BK (10 6 M) on initial rate of FL (1 AM) uptake in intact
rabbit renal proximal S2 tubules. All values are normalized to the last
control measurement. Symbols are meansF S.E. for each value plotted
(n= 6). *P < 0.05 vs. last control value; #P< 0.05 vs. last value in presence
of BK (from Ref. [47] with permission).
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and perfused tubules [48]. In addition, we showed that PMA
does not work by inhibiting aKG production in the cells
because it is even more effective in reducing FL uptake by
nonperfused tubules when the tubules are supplied with
sufficient exogenous aKG to keep the OA/aKG exchanger
not only minimally supplied but stimulated [47]. Thus, there
is now evidence that this transporter is regulated by phys-
iological stimuli (e.g., hormones or the autonomic nervous
system) in intact tubules via activation of PKC. However, as
suggested by recent work on the cloned mouse OAT1
expressed in LLC-PK1 cells, this may not involve direct
phosphorylation of mOAT by PKC [49].
Other recent data indicate that epidermal growth factor
(EGF), which appears to be important in normal tubulo-
genesis or tubular regeneration after injury, can enhance
basolateral uptake of OA in OK cells, which normally
contain the OA transport system [50]. This effect, in the
OK cell line, appears to occur via the mitogen-activated
protein kinase (MAPK) pathway because it is abolished by
inhibition of mitogen-activated/extracellular signal-regu-
lated kinase kinase (MEK) and because administration of
EGF leads to phosphorylation of extracellular signal-regu-
lated kinase 1 and 2 (ERK 1/2) [50]. Our preliminary data
also indicate that EGF stimulates PAH uptake by intact
rabbit tubules and that this stimulation is eliminated by
inhibition of MEK [51]. Therefore, at least a number of
physiological factors appear to regulate the basolateral OA
transporter by a number of phosphorylation pathways.
5. Luminal transport
During the process of net transepithelial secretion of
OAs, they move from the cells to the tubule lumen down
their electrochemical gradient (Fig. 1). This process must be
mediated in some fashion to account for the relatively high
apparent permeability of the membrane to substances with
relatively poor lipid solubilities (Table 2). However, this
transport process is much less well understood than that at
the basolateral membrane. Indeed, the basic process may
differ between vertebrate classes and between species within
a given vertebrate class.
A number of studies of this process have been made in
fishes, reptiles, and mammals. Studies with flounder brush
border membrane vesicles (BBMV) suggest that this process
involves carrier-mediated diffusion driven by the electrical
gradient [20], but other work with intact flounder tubules
does not support this observation (D.S. Miller, personal
communication). We have studied the process with isolated,
perfused snake renal tubules. In these tubules, movement of
PAH from the cells to the lumen is inhibited by SITS [24],
suggesting that it may involve anion exchange. However, in
contrast to what would be expected in this case, the move-
ment of radiolabeled PAH into the lumen is inhibited by
unlabeled PAH or phenol red in the lumen rather than
stimulated [52]. Of course, anion exchange could still be
occurring but the loaded carrier be translocating more
Fig. 13. Effect of PKC inhibitor BIM (10 7 M) on inhibition of initial rate
of FL (1 mM) uptake produced by PMA, BK, or PE. Columns show change
in FL uptake after 25 min exposure vs. last control value under different
conditions. Values are meansF S.E. (n= 6). resp., respective. Modified
from figures in Ref. [47] with permission.
Fig. 12. Effect of PE (10 6 M) on initial rate of FL (1 AM) uptake in intact
rabbit renal proximal S2 tubules. All values are normalized to last control
measurement. Symbols are meansF S.E. for each value plotted (n= 6).
*P < 0.05 vs. last control value; #P< 0.05 vs. last value in presence of BK.
From Ref. [47] with permission.
W.H. Dantzler / Biochimica et Biophysica Acta 1566 (2002) 169–181178
slowly than the unloaded carrier. The movement of PAH
into the lumen is not dependent on the presence of chloride
in the lumen, but substitutions for chloride suggest that it
may be dependent on the presence of an anion in the lumen
to which the membrane is highly permeable [53]. This could
be further evidence for anion exchange or it could result
from an effect on membrane potential. Of particular interest
in snake tubules is the observation that anything that inhi-
bits PAH movement from the cells to the lumen seconda-
rily results in a reduction in PAH uptake across the
basolateral membrane, suggesting some type of feedback
system between these two membrane transporters (Fig. 1)
[24,52,53].
In mammals, the situation is even more confusing
because there appear to be many variations among species.
For example, studies with BBMV from species whose
proximal tubules reabsorb urate (e.g., dogs and rats) give
evidence for an anion exchanger that can transport PAH
(and numerous other anions), but that appears to be poised
in the direction of reabsorbing urate [54–59]. Moreover,
this exchanger appears to be absent in BBMV from rabbits
and pigs, species whose kidneys secrete urate [54,59,60,61].
Indeed, there is some evidence from rabbit and pig BBMV
for carrier-mediated diffusion driven by the membrane
potential [60,61,62]. In addition, studies with bovine and
human BBMVeven provide some evidence for a PAH/aKG
exchanger in this membrane [63,64], although how two
exchangers of the same type in both membranes might be
poised to produce net transport of OAs from peritubular side
to luminal side of the tubule is not clear. Finally, there is
some evidence that the rabbit luminal Type I Na+-phosphate
cotransporter (NaPi-1) (a weak phosphate co-transporter)
may function as an electrogenic carrier or channel for OAs
when expressed in Xenopus oocytes [65].
It is obvious that very little is understood about this
luminal transport step. We are approaching this problem in
two ways. First, we have designed a system that makes it
possible for us to examine transport of FL from the cells to
the lumen across this membrane in real time [66]. The
method involves efflux of FL across the luminal membrane
of a perfused tubule in real time. Initial data with this system
are shown for a rabbit tubule in Fig. 14. These data show
clearly that the transport step saturates. The kinetic analysis
of these data [66] when compared with the analysis for net
transepithelial transport [34] support the concept that the
transport step at the basolateral membrane is rate-limiting
for net secretion.
Second, we are approaching this problem from a molec-
ular direction. One of the OAT family of OA transporters
isolated from the rat and human kidneys, OAT4, appears to
be located at the luminal membrane of the proximal tubule,
at least in humans [67]. Moreover, although this isolated
protein, when expressed in Xenopus oocytes, supports PAH
transport, it apparently does not support PAH/aKG
exchange or PAH transport against an electrochemical
gradient [67]. Therefore, it seems to be a potential candidate
for a luminal transporter. We are working to express both
OAT4 and OAT1 in the same cell system to determine if,
together, they can support transepithelial transport.
6. Intracellular transport
Most people have assumed that OAs, such as FL or PAH,
transported into the renal tubule cells at the basolateral
membrane diffuse through the cells to the luminal mem-
brane during the process of net transepithelial transport. In
recent years, however, some questions have been raised
about this assumption. Indeed, early studies had suggested
that intracellular binding of other transported substrates,
such as probenecid and phenol red, might occur [68,69],
but this was not supported by further studies [70]. More
recently, Miller and Pritchard and their co-workers [71,72]
using epifluorescence video-imaging and confocal micro-
scopy techniques to study transepithelial transport of FL in
flounder renal tubules, crab urinary bladder, and OK cells
have obtained evidence for accumulation of this OA in
punctate compartments (possibly vesicles). We have per-
formed some similar preliminary studies with isolated renal
tubules from rabbit, snake, and chicken kidneys ([73]; S.
Shpun and W.H. Dantzler, unpublished observations). Our
initial studies performed with a Tris-buffered medium iden-
tical to that used by Miller et al. [71] indicated that FL does
accumulate in punctate compartments in the cells of isolated
Fig. 14. Sample tracing showing consecutive washout profiles of FL
obtained from a single rabbit renal proximal S2 tubule in real time. The
concentration of FL in the collected perfusate is indicated on a log scale on
the ordinate. Time is indicated on a linear scale on the abscissa. The tubule
was exposed to 50 mM FL until a steady-state was obtained. FL was then
removed from the bathing medium and the disappearance of FL from the
collected perfusate (reflecting efflux) was observed. In the first two profiles,
the bathing medium remained standard bicarbonate-buffered medium when
FL was removed from it. Under these circumstances, efflux of FL from the
tubule occurs across both the luminal and basolateral membranes. In the
third profile, the bathing medium was simply replaced by mineral oil. With
the oil-covered tubule, efflux occurs only across the luminal membrane. In
this case, the luminal efflux is clearly shown to saturate and kinetic
constants can be determined from the saturation curves. Modified from Ref.
[66] with permission.
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rabbit proximal S2 tubules (and possibly in the cells of
snake and chicken proximal tubules). However, with the
rabbit tubules in this bicarbonate-free buffer, as might be
expected from our observations about buffers noted above,
very little FL appears in the tubule lumens. When the
medium bathing the tubules is replaced with a bicarbon-
ate/CO2-buffered one (with or without Tris), FL appears in
the lumen and no longer appears in punctate compartments
in the cytoplasm. We have not yet examined the effect of
different buffers in tubules from nonmammalian vertebrates,
but judging by the lack of effect of different buffers on OA
transport in snake tubules (see above), it may not make a
difference in these species. In any case, it appears that in
mammals, cellular metabolism is important in determining
the degree of accumulation in intracellular compartments
and that such accumulation may not be a factor in transport
under physiological conditions.
7. Conclusions
In all those vertebrates studied, the general system for the
transepithelial renal secretion of a wide range of hydro-
phobic OAs involves transport into the cells of the proximal
tubules against an electrochemical gradient at the basolateral
membrane by countertransport for aKG moving down its
electrochemical gradient (Fig. 1). This is the dominant, rate-
limiting step in the transepithelial secretory process. The
outwardly directed gradient for aKG at the basolateral
membrane is maintained by metabolism and by uptake
across both the basolateral and luminal membranes by
Na+-dicarboxylate cotransporters (Fig. 1). In mammals,
but not in nonmammalian species, we now have information
on the relative importance of these processes in maintaining
the gradient. We also now know that this basolateral trans-
port step is regulated under physiological conditions and we
are beginning to obtain information about several apparent
regulatory systems in mammals. These include peptide
hormones (e.g., BK) and the autonomic nervous system
working via PKC pathways and EGF working via the
MAPK pathway.
Within the cells, movement of these OAs to the luminal
side may involve diffusion, especially in mammalian
tubules under physiological conditions. However, under
some circumstances in mammalian tubules (e.g., when the
metabolic state is compromised) and possibly more gener-
ally in nonmammalian tubules, it may involve accumulation
in some form of vesicles, which then move across the cells
(Fig. 1).
Movement of OAs from the cells to the lumen across the
luminal membrane is clearly mediated in some fashion (Fig.
1), but the nature of such mediated transport is not
adequately understood for any species. Indeed, this transport
step may vary among vertebrate classes and among species
within any one vertebrate class. We now have preliminary
direct evidence on the saturation kinetics of this transporter
in rabbit proximal tubules and are working on at least one
possible molecular mechanism.
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